Inflation Reduction Act Research Series: Projecting The Impact Of The $2,000 Part D Out-Of-Pocket Cap For Medicare Part D Enrollees With High Prescription Drug Spending

On January 13, 2025, the U.S. Office of Health Policy published this Inflation Reduction Act Research Series issue brief projecting the impact of the $2,000 Medicare Part D out-of-pocket cap for enrollees with high prescription drug spending. The issue brief reports the results of a simulation model to identify how the Inflation Reduction Act of 2022 (IRA) cap may impact enrollees with high prescription drug costs . . .